Skip to main content
SpringerLink
Log in

Primary Colorectal Cancer

  • Chapter
  • First Online:
Intraoperative Irradiation

Part of the book series: Current Clinical Oncology ((CCO))

Abstract

Carcinoma of the rectum is a heterogeneous disease. At one end of the clinical spectrum, a small number of patients present with superficially invasive cancers who are well served by limited ­procedures, such as local excision or endocavitary irradiation. The great majority of patients with rectal cancer, however, have mobile but more deeply invasive tumors that require low anterior or abdominoperineal resection. At the other and less favorable end of the clinical spectrum, a subset of patients present with locally advanced tumors that are adherent or fixed to adjoining structures such as the sacrum, pelvic sidewalls, prostate, or bladder.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wang CC, Schulz MD. The role of radiation therapy in the management of carcinoma of the sigmoid, rectosigmoid, and rectum. Radiology. 1962;79:1–5.

    PubMed  CAS  Google Scholar 

  2. O’Connell MJ, Childs DS, Moertel CG, et al. A prospective controlled evaluation of combined pelvic radiotherapy and methanol extraction residue of BCG (MER) for locally unresectable or recurrent rectal carcinoma. Int J Radiat Oncol Biol Phys. 1982;8:1115–9.

    PubMed  Google Scholar 

  3. Brierley JD, Cummings BJ, Wong CS, Keane TJ, et al. Adenocarcinoma of the rectum treated by radical external radiation therapy. Int Radiat Oncol Biol Phys. 1995;31:255–9.

    Article  CAS  Google Scholar 

  4. Allee PE, Tepper JE, Gunderson LL, et al. Postoperative radiation therapy for incompletely resected colorectal carcinoma. Int J Radiat Oncol Biol Phys. 1989;17:1171–6.

    Article  PubMed  CAS  Google Scholar 

  5. Schild SE, Martenson JA, Gunderson LL, et al. Long-term survival and patterns of failure after postoperative radiation therapy for subtotally resected rectal adenocarcinoma. Int J Radiat Oncol Biol Phys. 1988;16:459–63.

    Google Scholar 

  6. Ghossein NA, Samala EC, Alpert S, et al. Elective postoperative radiotherapy after incomplete resection of colorectal cancer. Dis Colon Rectum. 1981;24:252–6.

    Article  PubMed  CAS  Google Scholar 

  7. Emami B, Pilepich M, Willett CG, Munzenrider JE, Miller HH. Effect of preoperative irradiation on resectability of colorectal carcinomas. Int J Radiat Oncol Biol Phys. 1982;8:1295–9.

    Article  PubMed  CAS  Google Scholar 

  8. Dosoretz DE, Gunderson LL, Hedberg S, et al. Preoperative irradiation for unresectable rectal and rectosigmoid carcinomas. Cancer. 1983;52:814–8.

    Article  PubMed  CAS  Google Scholar 

  9. Mendenhall WM, Bland KI, Pfaff WW, et al. Initially unresectable rectal adenocarcinoma treated with preoperative irradiation and surgery. Ann Surg. 1987;205:41–4.

    Article  PubMed  CAS  Google Scholar 

  10. Stevens KR, Fletcher WS. High dose preoperative pelvic irradiation for unresectable adenocarcinoma of the rectum or sigmoid. Int J Radiat Oncol Biol Phys. 1983;9:148.

    Google Scholar 

  11. Whiting JF, Howes A, Osteen RT. Preoperative irradiation for unresectable carcinoma of the rectum. Surgery (Gynecology & Obstetrics). 1993;176:203–7.

    CAS  Google Scholar 

  12. Marsh PJ, James RD, Scholfield PF. Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma. Dis Colon Rectum. 1994;37:1205–14.

    Article  PubMed  CAS  Google Scholar 

  13. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–40.

    Article  PubMed  CAS  Google Scholar 

  14. Braendengen M, Tveit KM, Berglund A, et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol. 2008;26:3687–94.

    Article  PubMed  CAS  Google Scholar 

  15. Weinstein GD, Rich TA, Shumate CR, Skibber JM, et al. Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer. Int J Radiat Oncol Biol Phys. 1995;32:197–204.

    PubMed  CAS  Google Scholar 

  16. Bd M, Cohen AM, Enker WE, Saltz L, et al. Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer. Int J Radiat Oncol Biol Phys. 1997;37:289–95.

    Article  Google Scholar 

  17. Prykolm G, Glimelius B, Pahlman L. Preoperative irradiation with and without chemotherapy (MFL) in the treatment of primary non-resectable adenocarcinoma of the rectum. Results from two consecutive studies. Eur J Cancer Clin Oncol. 1989;25:1535–41.

    Article  Google Scholar 

  18. Chan A, Wong A, Langevin J, Khoo R. Preoperative concurrent 5-fluorouracil infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma. Int J Radiat Oncol Biol Phys. 1992;25:791–9.

    Google Scholar 

  19. Chen ET-TSU, Mohiuddin M, Brodovsky H, Fishbein G, Marks G. Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation. Int J Radiat Oncol Biol Phys. 1994;30:169–75.

    PubMed  CAS  Google Scholar 

  20. Landry G, Koretz MJ, Wood WC, Bahri S, et al. Preoperative irradiation and fluorouracil chemotherapy for locally advanced rectosigmoid carcinoma: phase I-II study. Radiology. 1993;188:423–6.

    PubMed  CAS  Google Scholar 

  21. O’Connell MJ, Martenson JA, Wieand HS, et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion 5-FU with radiation therapy after curative surgery. N Engl J Med. 1995;331:502–7.

    Article  Google Scholar 

  22. Tepper JE, O’Connell M, Petroni G, et al. Toxicity in the adjuvant therapy of rectal cancer. Proc ASCO. 1996;15:210.

    Google Scholar 

  23. Gunderson LL, Cohen AM, Dosoretz DE, Shipley WU, et al. Residual, unresectable, or recurrent colorectal cancer: external beam irradiation and intraoperative electron beam boost ± resection. Int J Radiat Oncol Biol Phys. 1983;9:1597–606.

    PubMed  CAS  Google Scholar 

  24. Willett CG, Shellito PC, Tepper JE, Eliseo R, Convery K, Wood WC. Intraoperative electron beam radiation therapy for primarily locally advanced rectal and rectosigmoid carcinoma. J Clin Oncol. 1991;9:843–9.

    PubMed  CAS  Google Scholar 

  25. Willett CG, Shellito PC, Rodkey GV, Wood WC. Preoperative irradiation for tethered rectal cancer. Radiother Oncol. 1991;21:141–2.

    Article  PubMed  CAS  Google Scholar 

  26. Willett CG, Shellito PC, Gunderson LL. Primary colorectal EBRT and IOERT. In: Gunderson LL, Willett CG, Harrison LB, Calvo FC, editors. Intraoperative irradiation: techniques and results. Totowa, NJ: Humana; 1999. p. 249–72.

    Google Scholar 

  27. Gunderson LL, Martin JK, Beart RW, Nagorney DM, et al. External beam and intraoperative electron irradiation for locally advanced colorectal cancer. Ann Surg. 1988;207:52–60.

    Article  PubMed  CAS  Google Scholar 

  28. Gunderson LL, Nelson H, Martenson JA, Cha S, et al. Locally advanced primary colorectal cancer: intraoperative electron and external beam irradiation ± 5-FU. Int J Radiat Oncol Biol Phys. 1997;37:601–14.

    Article  PubMed  CAS  Google Scholar 

  29. Mathis KL, Nelson H, Pemberton JH, et al. Unresectable colorectal cancer can be cured with multimodality therapy. Ann Surg. 2008;248:592–8.

    PubMed  Google Scholar 

  30. Azinovic I, Calvo FA, Aristu JJ, Martinez R, et al. Intraoperative radiation therapy as a treatment component in primary rectal cancer: ten-year experience (personal communication).

    Google Scholar 

  31. Calvo FA, Gomez-Espi M, Diaz-Gonzalez JA, et al. Intraoperative presacral electron boost following preoperative chemoradiation in T3-4Nx rectal cancer: initial local effects and clinical outcome analysis. Radiother Oncol. 2002;62:201–6.

    Article  PubMed  Google Scholar 

  32. Diaz-Gonzalez JA, Calvo FA, Cortes J, et al. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation. Int J Radiat Oncol Biol Phys. 2006;64:1122–8.

    Article  PubMed  Google Scholar 

  33. Gomez Espi M, Calvo FA, Gonzalez C, et al. Timing and intensity of neoadjuvant treatment in rectal cancer: results of pre (plus IOERT) vs. post (no IOERT) chemoradiation. ISIORT 2008 Proceedings. Rev Cancer. 2008;22:45.

    Google Scholar 

  34. Krempien R, Roeder F, Oertel S, et al. Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2006;66:1143–51.

    Article  PubMed  Google Scholar 

  35. Rutten H, Valentini V, Krempien R, Calvo FA, European Working Party of ISIORT. Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer. ISIORT 2008 Proceedings. Rev Cancer. 2008;22:45–6.

    Google Scholar 

  36. Harrison LB, Minsky BD, Enker WE, et al. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 1998;42:325–30.

    PubMed  CAS  Google Scholar 

  37. Nuyttens JJ, Kolkman-Deurloo IK, Vermaas M, et al. High-dose-rate intraoperative radiotherapy for close or positive margins in patients with locally advanced or recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 2004;58:106–12.

    Article  PubMed  Google Scholar 

  38. Kim HK, Jessup M, Beard CJ, Bornstein B, et al. Locally advanced rectal carcinoma: pelvic control and morbidity following preoperative radiation therapy, resection and intraoperative radiation therapy. Int J Radiat Oncol Biol Phys. 1997;38(4):777–83.

    Article  PubMed  CAS  Google Scholar 

  39. Gillette SM, Gillette EL, Vujaskovic Z, Larua SM, Park RD. Influence of volume on intraoperatively irradiated canine ureters. Fifth international IORT abstracts. Hepatol Gastroenterol. 1994;41:28.

    Google Scholar 

  40. Erlichman C, Fine S, Wong A, Elhakeim T. A randomized trial of 5-fluorouracil (5-FU) and folinic acid (FA) in metastatic colorectal carcinoma. J Clin Oncol. 1988;6:469–75.

    PubMed  CAS  Google Scholar 

  41. Poon MA, O’Connell MJ, Moertel CG, Wieand HS, et al. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol. 1989;7:1407–18.

    PubMed  CAS  Google Scholar 

  42. O’Connell M, Mailliard J, Kahn MJ, MacDonald J, et al. An intergroup trial of intensive 5-FU and low dose leucovorin as surgical adjuvant therapy for high risk colon cancer. J Clin Oncol. 1997;15:246–50.

    PubMed  Google Scholar 

  43. Wolmark N, Rockette H, Fisher B, Wichersham DL, et al. The benefit of leucovorin-modulated 5-FU (LV-5-FU) as postoperative adjuvant therapy for primary colon cancer: results from NSABP C-03. J Clin Oncol. 1993;11:1879–87.

    PubMed  CAS  Google Scholar 

  44. Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343–51.

    Article  PubMed  CAS  Google Scholar 

  45. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335–42.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Massachusetts General Hospital, 100 Blossom St., Cox 3, Boston, MA, 02114, USA

    Nils D. Arvold & Theodore S. Hong

  2. Department of Radiation Oncology, Duke University Medical Center, Durham, NC, 27710, USA

    Christopher G. Willett & Brian Czito

  3. Department of Surgery, Massachusetts General Hospital and Harvard Medical School, 15 Parkman Street, WACC 336, Boston, MA, 02114, USA

    Paul C. Shellito

  4. Department of Radiation Oncology, Mayo Clinic Cancer Center, 200 First St SW, Rochester, MN, 55905, USA

    Michael G. Haddock

  5. Department of Surgery, Catharina Hospital, Michelangelolaan 2, 5623, ZA, Eindhoven, The Netherlands

    Harm Rutten

  6. Department of Radiotherapy, Universita Cattolica del Sacro Cuore, Largo A. Gemelli, 8, 00168, Rome, Italy

    Vincenzo Valentini

  7. Department of Oncology, Hospital Gregorio Maranón, Dr. Esquerdo 46, 28007, Madrid, Spain

    Felipe A. Calvo

  8. Department of Radiation Oncology, Mayo Clinic College of Medicine and Mayo Clinic Arizona, Scottsdale, AZ, USA

    Leonard L. Gunderson

Authors
  1. Nils D. Arvold
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Theodore S. Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christopher G. Willett
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paul C. Shellito
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael G. Haddock
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Harm Rutten
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Vincenzo Valentini
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Felipe A. Calvo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Brian Czito
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Leonard L. Gunderson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nils D. Arvold .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Mayo Clinic, East Shea Blvd 13400, Scottsdale, 85259, Arizona, USA

    Leonard L. Gunderson

  2. Dept. Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA

    Christopher G. Willett

  3. Gregorio Marañón, Depto. Radiación de Oncología, Hospital General Universitario, C/ Dr. Esquerdo 46, Madrid, 28007, Spain

    Felipe A. Calvo

  4. Albert Einstein College of Medicine, Radiation Oncology, Beth Israel Medical Center, Union Square East 10, New York, 10003, New York, USA

    Louis B. Harrison

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Arvold, N.D. et al. (2011). Primary Colorectal Cancer. In: Gunderson, L., Willett, C., Calvo, F., Harrison, L. (eds) Intraoperative Irradiation. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-61779-015-7_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-015-7_15

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-61779-014-0

  • Online ISBN: 978-1-61779-015-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation